✦ LIBER ✦
Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
✍ Scribed by van den Neste, Eric; Letestu, Rémi; Aurran-Schleinitz, Thérèse; Ysebaert, Loïc; Feugier, Pierre; Leprêtre, Stéphane; Dartigeas, Caroline
- Book ID
- 111922932
- Publisher
- Informa plc
- Year
- 2011
- Tongue
- English
- Weight
- 236 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1042-8194
No coin nor oath required. For personal study only.